A compact inhaler that subtly adjusts the body's natural molecules offers promising drug-free relief for certain migraine patients, potentially shortening or eliminating medication needs. This pilot study focused on individuals with migraines accompanied by aura—sensory or visual disturbances preceding intense headaches. Eleven participants joined the trial, setting the stage for a larger clinical study.
Lead researcher Dr. [Name withheld] explains that migraines spark a chain reaction: brain blood vessels constrict, starving the brain of oxygen.
“Using CO2 and oxygen—the body’s own molecules—we activate its defenses. The inhaler widens vessels, delivering up to 70% more oxygen to the brain and halting the attack in seconds,” notes the researcher.
From 2016-2017, the study tracked 11 aura migraine patients. Pain relief efficacy grew with use: 40% benefited first time, rising to 78% on the second.
